Challenge a draft interpretation before it reaches human sign-off.
This existing Tynixa capability is integrated as a product workflow. It supports audit-ready, human-reviewed genomic review using synthetic or de-identified demo context.
Open review package demo is available as the safe package-context path for this capability.
Signals can be attached to a review-ready package for qualified human review.
Uncertainty, conflicts, and policy blocks route to reviewer or lab director workflows.
The demo shows evidence maturity, governance, and pilot readiness without unsafe claims.
Look for evidence that may weaken or challenge a draft interpretation before human review.
Reviewers, labs, and researchers stress-testing a draft package.
A safe example of challenge signals, review prompts, and next evidence actions.
No final diagnosis. Counter-evidence does not declare a final classification; it supports review.
A synthetic variant draft is flagged for insufficient functional evidence and conflicting public records.
Open review package context, inspect evidence gaps, or continue to reviewer mode.